「The baseline recurrence risk of patients with intermediate-risk cervical cancer.」の関連論文
-
Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer (本文)
-
Clinical characteristics and risk factors for mortality in patients with community-acquired staphylococcal pneumonia
-
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors
-
Current status and management of pancreatic trauma with main pancreatic duct injury : A multicenter nationwide survey in Japan
-
Texture indices of 4′-[methyl-11C]-thiothymidine uptake predict p16 status in patients with newly diagnosed oropharyngeal squamous cell carcinoma : comparison with 18F-FDG uptake
-
Study on the analysis of gastrointestinal positional variations and the efficacy of online adaptive radiation therapy for improving the treatment outcomes of locally advanced pancreatic cancer
-
Development and validation of a prognostic model for non-lung cancer death in elderly patients treated with stereotactic body radiotherapy for non-small cell lung cancer
-
Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients (本文)
-
Endoscopy-focused primary, secondary and tertiary prevention of colorectal cancer
-
The expression of carcinoembryonic antigen mRNA in the lavage of the dissected area of the lateral lymph nodes influences the lateral recurrence of lower rectal cancer
-
Prototype Single-Balloon Enteroscopy With Passive Bending and High Force Transmission Improves Depth of Insertion in the Small Intestine.
-
Nonexposed wall-inversion surgery as a novel local resection method for neoplasms in the gastrointestinal tract
-
Occurrence of cholangiocarcinoma, three years after negative seroconversion of anti-TIF1γ antibody, in a dermatomyositis patient
-
Obesity and narrow pelvis prolong the operative time in conventional laparoscopic rectal cancer surgery, but not in a two-team transanal total mesorectal excision approach
-
Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors (本文)
-
Risk factors for cisplatin-induced acute kidney injury: A pilot study on the usefulness of genetic variants for predicting nephrotoxicity in clinical practice
-
Tumor volume shrinkage during stereotactic body radiotherapy is related to better prognoses in patients with stage I non-small-cell lung cancer
-
Systemic therapy for salivary gland malignancy: current status and future perspectives
-
転移性胃癌に対してPaclitaxel/Ramucirumab併用療法中に難治性の間歇的血尿を来たした1例
-
Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
-
A new clinical classification and reconstructive strategy for post-sternotomy surgical site infection
-
Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial)
-
Differentiation between pancreatic metastases from renal cell carcinoma and pancreatic neuroendocrine neoplasm using endoscopic ultrasound
-
Clinical Characteristics and Surgical Outcomes of Metastatic Spine Tumors in the Very Elderly: A Prospective Cohort Study in a Super-Aged Society
-
Consumption of coffee and antioxidant vitamins and risk of lung cancer in Japan
-
Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trial
-
Prognostic stratification for IDH-wild-type lower-grade astrocytoma by Sanger sequencing and copy-number alteration analysis with MLPA
-
Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer
-
Pancreas-visceral fat CT value ratio and serrated pancreatic contour are strong predictors of postoperative pancreatic fistula after pancreaticojejunostomy
-
ロボット支援腹腔鏡下腎部分切除術後仮性動脈瘤の自然消退に関する臨床的検討
-
腎摘除術を要した重症腎感染症の後方視的検討
-
Phase III clinical trial of autologous CD34 + cell transplantation to accelerate fracture nonunion repair
-
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma
-
Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma
-
Clinical impact of spacer placement surgery with expanded polytetrafluoroethylene sheet for particle therapy
-
Peroral endoscopic myotomy for advanced achalasia with megaesophagus
-
Pregnancy outcomes after hysteroscopic surgery in women with cesarean scar syndrome.
-
Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients
-
Prospective Evaluation of Health-Related Quality of Life in Patients Undergoing Anterolateral Craniofacial Resection with Orbital Exenteration
-
セツキシマブ併用放射線治療中にニューモシスチス肺炎を発症し,診断に苦慮した1例
-
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
-
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
-
Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study
-
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome.
-
Vascularized Bone Graft to the Lunate Combined With Temporary Scaphocapitate Fixation for Treatment of Stage III Kienböck Disease: A Report of the Results, a Minimum of 2 Years After Surgery
-
Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients
-
Development of radiomics and machine learning model for predicting occult cervical lymph node metastasis in patients with tongue cancer
-
Development of radiomics and machine learning model for predicting occult cervical lymph node metastasis in patients with tongue cancer
-
A novel surgical treatment for labial adhesion – The combination of Z- and Y-V-plasty : A case report.
-
Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model